Form 4 holding
Director
Processa Pharmaceuticals, Inc.
- Security class
- Series A Preferred Stock
- Shares / value
- 70,812
- Estimated value
- Report date
- 28 Jul 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount